Bernd Giebel

Prof. Dr. Bernd Giebel is a leading faculty member at the Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen. He leads the Giebel Lab, which is dedicated to advancing the understanding and clinical application of extracellular vesicles (EVs), particularly those derived from mesenchymal stromal cells (MSCs). His research spans hematopoietic progenitor biology and EV-based therapeutics for inflammatory and neurological conditions.

His research focuses on elucidating the therapeutic potential of MSC-derived EVs, having demonstrated efficacy in treating graft-versus-host disease and ischemic brain injury. His lab pioneers methods for EV isolation and characterization, including free-flow electrophoresis and imaging flow cytometry. He is deeply involved in standardizing EV research through initiatives like MISEV and EV-TRACK.

The recent publications highlight a strong trend toward clinical translation, with work on optimizing EV manufacturing, functional assays, and biomarker discovery. His team investigates EVs in stroke, neuroprotection, immunomodulation, and cancer immunotherapy, often using advanced preclinical models and multi-omics approaches.

• Founding President, German Society of Extracellular Vesicles (2017–2023)
• Chair, Exosome Committee, International Society for Cell & Gene Therapy (ISCT)
• Co-initiator, Mobility for Vesicles in Europe (MOVE)
• Active member, International Society for Extracellular Vesicles (ISEV)

Bernd Giebel mentors several PhD students and postdoctoral researchers, fostering the next generation of EV scientists. His lab collaborates extensively with national and international experts, contributing to influential white papers and consensus guidelines. The research is supported by ongoing projects and publications in top-tier journals, indicating sustained funding and academic leadership.

The Giebel Lab operates within the Institute for Transfusion Medicine and is part of the broader research ecosystem at University Hospital Essen, focusing on translational medicine and regenerative therapies.